ILMN

Illumina, Inc.

Technology

262.54 -5.39 -2.01% Pre-Market

2026-10-16 • USD

Key Metrics

Market Cap 39.64B

EV 39.01B

Shares Out 151.00M

Revenue (ttm) —

Net Income 1.01B

Beta —

P/E —

Forward P/E —

EPS (ttm) $6.59

P/S —

P/B 13.97

P/FCF —

P/C —

EV/Sales —

EV/EBITDA —

ROA 15.17%

ROE 38.67%

ROIC —

Gross Margin —

Oper. Margin —

Profit Margin —

Debt/Eq 0.19

LT Debt/Cap —

Quick Ratio 1.22

Current Ratio 1.80

Book/sh 18.79

Cash/sh 6.89

Div Yield —

Div TTM —

Payout Ratio —

SMA20 -2.21%

SMA50 12.23%

SMA200 54.75%

Volume 2,490,274

Avg Volume 2.53M

Rel Volume 0.98

Perf Week -5.11%

Perf Month 9.57%

Perf Quarter 40.66%

Perf Half Y 95.20%

Perf YTD 100.17%

Perf Year 175.03%

Perf 3Y 125.16%

Perf 5Y -34.76%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Illumina, Inc. is a global leader in sequencing- and array-based solutions for genetic and genomic analysis. The company develops and markets integrated sequencing and microarray…

Name: Illumina, Inc.
Sector: Technology
Industry: Technology
CEO: Jacob Thaysen · Chief Executive Officer
Employees: 7,500 as of 2025-12-28
IPO Date: 2018-11-05
Phone: (858) 202-4500
Address: 5200 Illumina Way, San Diego, CA 92122
Website: www.illumina.com

Key Executives

Name	Title	FY Pay
Patricia Leckman	Chief People Officer	—
Ankur Dhingra	Chief Financial Officer	—
Scott Davies	Chief Legal Officer	—
Steven Barnard	Chief Technology Officer	—
Jacob Thaysen	Chief Executive Officer	—

Latest News

2026-04-25
Caprock Group LLC Purchases 5,764 Shares of Illumina, Inc. $ILMN defenseworld.net
2026-04-23
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth zacks.com
2026-04-23
Why Investors Need to Take Advantage of These 2 Medical Stocks Now zacks.com
2026-04-20
Fortis Capital Advisors LLC Invests $1.26 Million in Illumina, Inc. $ILMN defenseworld.net
2026-04-16
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows prnewswire.com
2026-04-15
Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of “Hold” by Brokerages defenseworld.net
2026-04-14
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease prnewswire.com
2026-04-13
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar zacks.com